Значения термина ccrcc patients на английском

We enrolled 129 CCRCC patients containing at least two different nuclear grades.

Two nomograms were constructed to predict clinical outcomes for ccRCC patients after surgery.

C5aR was an adverse independent prognostic factor for ccRCC patients.

Multivariate Cox regression analysis revealed that MRCCAT1 is an independent prognostic factor for ccRCC patients.

CD8 T cells with hyperpolarized mitochondria were also visible in the blood of ccRCC patients.

The increased miR-122 levels were associated with poor metastasis-free survival in ccRCC patients with localized disease.

In conclusion, high tumoral dectin-1 expression was an independent predictor of adverse clinical outcome in ccRCC patients.

Clinically, AXL expression in primary tumors of ccRCC patients correlates with aggressive tumor behavior and patient lethality.

Results: We included 129 m- ccRCC patients treated between 2005 and 2013.

The newly built nomograms could give better prediction for overall survival and recurrence free survival in ccRCC patients.

Tumor cells from ccRCC patients with VHL loss-of-function mutations usually had increased abundance and nuclear localization of ZHX2.

Although target therapy has significantly improved the prognosis of some ccRCC patients, the median survival rate remains poor.

Further research with the follow-up data of 129 ccRCC patients were analyzed by the Cox regression and survival analysis.

Cancer-specific survival (CSS) of ccRCC patients was significantly associated with gene expression similarity to the proximal tubules.

To evaluate the predictive and prognostic functions of RET in ccRCC , a tissue microarray study was conducted on 273 ccRCC patients.

Conclusions: The ClearCode34-based model provides prognostic stratification that improves upon established algorithms to assess risk for recurrence and death for nonmetastatic ccRCC patients.